Patients with FSCN1-positive HCC exhibit significantly poorer outcomes than patients with FSCN1-negative HCC, and FSCN1 is an independent prognostic factor for disease-free survival of HCC patients 65. This evidence concerns the gene FSCN1 and hepatocellular carcinoma.